IL182652A0 - Nitrobenzindoles and their use in cancer therapy - Google Patents
Nitrobenzindoles and their use in cancer therapyInfo
- Publication number
- IL182652A0 IL182652A0 IL182652A IL18265207A IL182652A0 IL 182652 A0 IL182652 A0 IL 182652A0 IL 182652 A IL182652 A IL 182652A IL 18265207 A IL18265207 A IL 18265207A IL 182652 A0 IL182652 A0 IL 182652A0
- Authority
- IL
- Israel
- Prior art keywords
- nitrobenzindoles
- cancer therapy
- cancer
- therapy
- Prior art date
Links
- GNDINQYCDXTGEO-UHFFFAOYSA-N 2-nitro-1h-benzo[g]indole Chemical class C1=CC=CC2=C(NC([N+](=O)[O-])=C3)C3=CC=C21 GNDINQYCDXTGEO-UHFFFAOYSA-N 0.000 title 1
- 238000011275 oncology therapy Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/572—Five-membered rings
- C07F9/5728—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/58—[b]- or [c]-condensed
- C07D209/60—Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NZ536107A NZ536107A (en) | 2004-10-22 | 2004-10-22 | Nitrobenzindoles and their use in cancer therapy |
| PCT/NZ2005/000278 WO2006043839A1 (en) | 2004-10-22 | 2005-10-21 | Nitrobenzindoles and their use in cancer therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL182652A0 true IL182652A0 (en) | 2007-07-24 |
Family
ID=36203204
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL182652A IL182652A0 (en) | 2004-10-22 | 2007-04-18 | Nitrobenzindoles and their use in cancer therapy |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US7718688B2 (enExample) |
| EP (1) | EP1809603A4 (enExample) |
| JP (1) | JP2008517905A (enExample) |
| KR (1) | KR20070083806A (enExample) |
| CN (1) | CN101044114B (enExample) |
| AU (1) | AU2005296389B2 (enExample) |
| BR (1) | BRPI0517285A (enExample) |
| CA (1) | CA2584702A1 (enExample) |
| IL (1) | IL182652A0 (enExample) |
| MX (1) | MX2007004596A (enExample) |
| NZ (1) | NZ536107A (enExample) |
| RU (1) | RU2007118938A (enExample) |
| WO (1) | WO2006043839A1 (enExample) |
| ZA (1) | ZA200703699B (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2008009956A (es) | 2006-02-02 | 2008-12-12 | Syntarga Bv | Analogos de cc-1065 solubles en agua y sus conjugados. |
| US9901567B2 (en) | 2007-08-01 | 2018-02-27 | Syntarga B.V. | Substituted CC-1065 analogs and their conjugates |
| US8076491B2 (en) | 2007-08-21 | 2011-12-13 | Senomyx, Inc. | Compounds that inhibit (block) bitter taste in composition and use thereof |
| AU2008289485B2 (en) | 2007-08-21 | 2014-08-14 | Senomyx, Inc. | Human T2R bitterness receptors and uses thereof |
| NZ571028A (en) * | 2008-09-03 | 2011-01-28 | Auckland Uniservices Ltd | Nitrobenzindole compounds and their use in cancer treatment |
| NO2344478T3 (enExample) * | 2008-11-03 | 2018-02-24 | ||
| MX374267B (es) | 2010-04-21 | 2025-03-06 | Syntarga Bv | Conjugados novedosos de analogos cc-1065 y ligaduras bifuncionales. |
| CN102827061A (zh) * | 2012-09-19 | 2012-12-19 | 兰州大学 | 5,6,7-三甲氧基吲哚类衍生物、制备方法及用途 |
| WO2014062856A1 (en) | 2012-10-16 | 2014-04-24 | Halozyme, Inc. | Hypoxia and hyaluronan and markers thereof for diagnosis and monitoring of diseases and conditions and related methods |
| SG10201911860VA (en) | 2014-01-10 | 2020-02-27 | Synthon Biopharmaceuticals Bv | Duocarmycin adcs showing improved in vivo antitumor activity |
| KR20160099725A (ko) | 2014-01-10 | 2016-08-22 | 신톤 바이오파머슈티칼즈 비.브이. | 자궁내막암의 치료에서 사용하기 위한 듀오카르마이신 adc |
| MX373458B (es) | 2014-01-10 | 2020-05-11 | Byondis Bv | Metodo para purificar conjugados de anticuerpo-farmaco enlazados a cisteina. |
| AU2015282627B2 (en) | 2014-06-30 | 2020-04-02 | Glykos Finland Oy | Saccharide derivative of a toxic payload and antibody conjugates thereof |
| JPWO2019004413A1 (ja) * | 2017-06-30 | 2020-05-07 | 東レ株式会社 | インドリン誘導体及びそれを含む細胞毒性剤 |
| CN112724068A (zh) * | 2020-12-30 | 2021-04-30 | 蔡桂坡 | 具有hdac抑制活性的吲哚类衍生物的合成方法及肿瘤应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE310725T1 (de) * | 1996-09-12 | 2005-12-15 | Auckland Uniservices Ltd | Kondensierte n-acylindole als antitumormittel |
| US7192977B2 (en) * | 2001-02-22 | 2007-03-20 | School Of Pharmacy | Benz-indole and benzo-quinoline derivatives as prodrugs for tumor treatment |
| AU2003228173A1 (en) * | 2002-05-17 | 2003-12-02 | Auckland Uniservices Limited | Processes for preparing 3-substituted 1-(chloromethyl)-1,2-dihydro-3h-(ring fused indol-5-yl(amine-derived)) compounds and analogues thereof, and to products obtained therefrom |
| NZ529249A (en) | 2003-10-31 | 2006-04-28 | Auckland Uniservices Ltd | Novel nitrophenyl mustard and nitrophenylaziridine alcohols and their corresponding phosphates and their use as targeted cytotoxic |
-
2004
- 2004-10-22 NZ NZ536107A patent/NZ536107A/en not_active IP Right Cessation
-
2005
- 2005-10-21 EP EP05800725A patent/EP1809603A4/en not_active Withdrawn
- 2005-10-21 US US11/666,014 patent/US7718688B2/en not_active Expired - Fee Related
- 2005-10-21 CA CA002584702A patent/CA2584702A1/en not_active Abandoned
- 2005-10-21 RU RU2007118938/04A patent/RU2007118938A/ru not_active Application Discontinuation
- 2005-10-21 MX MX2007004596A patent/MX2007004596A/es not_active Application Discontinuation
- 2005-10-21 AU AU2005296389A patent/AU2005296389B2/en not_active Ceased
- 2005-10-21 KR KR1020077009468A patent/KR20070083806A/ko not_active Ceased
- 2005-10-21 JP JP2007537835A patent/JP2008517905A/ja active Pending
- 2005-10-21 BR BRPI0517285-3A patent/BRPI0517285A/pt not_active Application Discontinuation
- 2005-10-21 WO PCT/NZ2005/000278 patent/WO2006043839A1/en not_active Ceased
- 2005-10-21 CN CN2005800362035A patent/CN101044114B/zh not_active Expired - Fee Related
-
2007
- 2007-04-18 IL IL182652A patent/IL182652A0/en unknown
- 2007-05-08 ZA ZA200703699A patent/ZA200703699B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN101044114B (zh) | 2012-02-15 |
| CA2584702A1 (en) | 2006-04-27 |
| AU2005296389A1 (en) | 2006-04-27 |
| US7718688B2 (en) | 2010-05-18 |
| NZ536107A (en) | 2007-06-29 |
| RU2007118938A (ru) | 2008-11-27 |
| EP1809603A1 (en) | 2007-07-25 |
| BRPI0517285A (pt) | 2008-10-07 |
| US20080119442A1 (en) | 2008-05-22 |
| KR20070083806A (ko) | 2007-08-24 |
| CN101044114A (zh) | 2007-09-26 |
| AU2005296389B2 (en) | 2012-03-15 |
| WO2006043839A1 (en) | 2006-04-27 |
| MX2007004596A (es) | 2007-06-22 |
| JP2008517905A (ja) | 2008-05-29 |
| EP1809603A4 (en) | 2009-09-02 |
| ZA200703699B (en) | 2008-10-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL182652A0 (en) | Nitrobenzindoles and their use in cancer therapy | |
| IL178012A0 (en) | Diphenyl-indol-2-on compounds and their use in the treatment of cancer | |
| EP2038041A4 (en) | THERAPEUTIC COMPOUNDS AND THEIR USE AGAINST CANCER | |
| TWI349551B (en) | Thiophenepyrimidinone derivatives and their use in therapy | |
| IL174994A0 (en) | Pyrimidin - 4 - yl - 3, 4 - thione compounds and their use in therapy | |
| AU2003293376A8 (en) | Anti-angiogenic compounds and their use in cancer treatment | |
| PL2287195T3 (pl) | Przeciwciała pan-kir2dl receptora nk i ich zastosowanie w diagnostyce i terapii | |
| SI1824855T1 (sl) | Novi pirolo derivati d pirimidin ona in njihova uporaba pri zdravljenju | |
| IL181608A0 (en) | Cancer combination therapy comprising azd2171 and imatinib | |
| GB0702696D0 (en) | Porphyrin derivatives and their use in photon activation therapy | |
| GB0418328D0 (en) | Cancer methods and medicaments | |
| TWI350286B (en) | Alkylpiperazine- and alkylhomopiperazine-carboxylate derivatives, their preparation and their application in therapy | |
| IL172826A0 (en) | Quinoline derivates and their use in therapy | |
| GB0523576D0 (en) | Drug composition and its use in therapy | |
| ZA200702093B (en) | Arene ruthenium (II) compounds and their use in cancer therapy | |
| EP1756166A4 (en) | DIAGNOSIS AND TREATMENT OF PROSTATE CANCER | |
| ZA200709542B (en) | Combination therapy in the treatment of cancer | |
| EP1838288A4 (en) | THERAPEUTIC MATERIALS AND METHODS | |
| GB0428170D0 (en) | Mono and Combination Therapy | |
| GB0326578D0 (en) | Cancer diagnosis and therapy | |
| IL164467A0 (en) | binding agents and their use in targeting tumor cells | |
| GB0407382D0 (en) | Therapeutic methods and means | |
| SI1639013T1 (sl) | Pan-kir2dl nk-receptorska protitelesca in njihova uporaba pri diagnosticiranju in terapiji | |
| IL185575A0 (en) | Benzoxazocines and their therapeutic use | |
| GB0700827D0 (en) | Hai-1 and Hai-2 in cancer therapy |